Abstract:Background Vascular calcification refers to the abnormal accumulation of calcium in the walls of blood vessels and is a risk factor often overlooked in cardiovascular disease. However, there is currently no specific drug for treating vascular calcification. Compound Danshen Dripping Pill (CDDP) is widely used to treat cardiovascular diseases, but its effect on vascular calcification has not been reported. Purpose We investigated the effects of CDDP on vascular calcification in ApoE −/− mice and in vitro and elucidated its mechanism of action. Study design Firstly, we found that CDDP has the potential to improve calcification based on network pharmacology analysis. Then, we performed the following experiments: in vivo , ApoE −/− mice were fed a high-fat diet randomly supplemented with CDDP for 16 weeks. Atherosclerosis and vascular calcification were determined. In vitro , human aortic smooth muscle cells (HASMCs), human umbilical vein endothelial cells (HUVECs), and human aortic endothelial cells (HAECs) were used to determine the mechanisms for CDDP-inhibited vascular calcification. Results In this study, we observed that CDDP reduced intimal calcification in atherosclerotic lesions of ApoE-deficient mice fed a high-fat diet, as well as the calcification in cultured SMCs and ECs. Mechanistically, CDDP inhibited the Wnt/β-catenin pathway by up-regulating the expression of DKK1 and LRP6, which are upstream inhibitors of Wnt, leading to a reduction in the expression of osteoblastic transition markers (ALP, OPN, BMP2, and RUNX2). Furthermore, CDDP enhanced the secretion of DKK1, which plays a role in mediating EC-SMC crosstalk in calcification. Additionally, VC contributes to vascular aging by inhibiting Sirt1 and increasing senescence parameters (SA-β-gal, p21, and p16). However, CDDP reversed these changes by activating Sirt1. CDDP also reduced the levels of pro-inflammatory cytokines and the senescence-associated secretory phenotype in vivo and in vitro . Conclusions Our study suggests that CDDP reduces vascular calcification by regulating the DKK1/LRP6/β-catenin signaling pathway in ECs/SMCs and interactions with the crosstalk of ECs and SMCs. It also reduces the senescence of ECs/SMCs, contributing to the Sirt1 activation, indicating CDDP's novel role in ameliorating vascular calcification.

Spermidine inhibits vascular calcification in chronic kidney disease through modulation of SIRT1 signaling pathway

Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α Inhibits Vascular Calcification Through Sirtuin 3-Mediated Reduction of Mitochondrial Oxidative Stress.

Intermedin Alleviates Vascular Calcification in CKD Through Sirtuin 3-Mediated Inhibition of Mitochondrial Oxidative Stress

Resveratrol Ameliorated Vascular Calcification by Regulating Sirt-1 and Nrf2.

Deletion of soluble epoxide hydrolase suppressed chronic kidney disease-related vascular calcification by restoring Sirtuin 3 expression

Sirt7 protects against vascular calcification via modulation of reactive oxygen species and senescence of vascular smooth muscle cells

Intermedin1-53 attenuates aging-associated vascular calcification in rats by upregulating sirtuin 1

High Phosphate-Induced Downregulation of PPARγ Contributes to CKD-associated Vascular Calcification

Intermedin1–53 Attenuates Vascular Calcification in Rats with Chronic Kidney Disease by Upregulation of Α-Klotho

Irisin alleviates vascular calcification by inhibiting VSMC osteoblastic transformation and mitochondria dysfunction via AMPK/Drp1 signaling pathway in chronic kidney disease

Calcitriol combined with high‐calcium and high‐phosphorus diet induces vascular calcification model in chronic kidney disease rats

Sclerostin is Involved in Osteogenic Transdifferentiation of Vascular Smooth Muscle Cells in Chronic Kidney Disease-Associated Vascular Calcification with Non-Canonical Wnt Signaling.

Inhibition of vascular calcification by Compound Danshen Dripping Pill through multiple mechanisms

Repression of the Antiporter SLC7A11/glutathione/glutathione Peroxidase 4 Axis Drives Ferroptosis of Vascular Smooth Muscle Cells to Facilitate Vascular Calcification

Indoxyl Sulfate Enhance the Hypermethylation of Klotho and Promote the Process of Vascular Calcification in Chronic Kidney Disease.

SIRT6 protects vascular smooth muscle cells from osteogenic transdifferentiation via Runx2 in chronic kidney disease

Overexpression of miR-204-5p Alleviates Osteogenic Differentiation and Calcification of Human Aortic Vascular Smooth Muscle Cells by Targeting Calcium/Calmodulin-dependent Protein Kinase 1

Up-regulation of heme oxygenase-1 by celastrol alleviates oxidative stress and vascular calcification in chronic kidney disease.

NRF2-suppressed vascular calcification by regulating the antioxidant pathway in chronic kidney disease

VX-765 Ameliorates CKD VSMC Calcification by Regulating STAT3 Activation.

Abstract 319: Intermedin Attenuates Vascular Calcification by Upregulating Klotho Via CRLR/RAMP3 Receptor Complex and Camp/pka Signaling Pathway in Rats with Chronic Kidney Disease